Progressive supranuclear palsy
Related Experiment Video
Updated: May 25, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
Loretta Mazorra1, Mary P Cadogan
1University of California, Los Angeles, CA, USA. anlom@sbcglobal.net
Abstract:
Progressive supranuclear palsy (PSP) is the second-most-common parkinsonian neurodegenerative disorder following Parkinson's disease. Although PSP was first identified clinically more than 40 years ago, it remains poorly recognized and underdiagnosed. Using an individual example, this article describes the epidemiology, neuropathology, clinical course, supportive management strategies, and resources for patients with PSP and their families.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll
Alterations in Muscle Tone ll
Huntington Disease l: Introduction
